<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00484133</url>
  </required_header>
  <id_info>
    <org_study_id>WO-06.068</org_study_id>
    <nct_id>NCT00484133</nct_id>
  </id_info>
  <brief_title>Microcirculation Guided Therapy Versus &quot;Standard Treatment&quot; of Severe Sepsis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Onze Lieve Vrouwe Gasthuis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Onze Lieve Vrouwe Gasthuis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to asses the recovery of organ failure between two resuscitation
      protocols in severe sepsis: standard, pressure guided therapy versus a microcirculation
      guided therapy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite continued improvements in medical therapy, mortality from septic shock has remained
      between 30% and 70% for the past three decades with only a slight decrease in mortality rate.
      Standard treatment of septic shock is fluid resuscitation, followed by agents with
      vasopressor activity to correct hypotension in septic shock. The question rises whether
      vasopressors should be the first line of action in septic shock Opening and recruiting the
      microcirculation are expected to improve regional organ function and tissue distress in
      severe sepsis. Beside fluid resuscitation, vasodilatation, in this respect, enhances
      microcirculatory flow while vasoconstriction causes a reduction in microcirculatory flow. On
      the other hand, a minimal perfusion pressure should be present. Our aim is to asses the
      effects of two resuscitation protocols in severe sepsis: the &quot;standard treatment&quot; using
      predefined pressure goals versus a microcirculation guided therapy.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2007</start_date>
  <primary_completion_date type="Anticipated">December 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in SOFA (Sequential Organ Failure Assessment) score during the first 72 hours of treatment for severe sepsis</measure>
    <time_frame>72 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severity, decrease and duration of organ failure over the complete ICU stay</measure>
    <time_frame>complete icu stay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of organ support</measure>
    <time_frame>during ICU treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU and hospital length of stay</measure>
    <time_frame>hospital stay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU and hospital mortality</measure>
    <time_frame>hospital stay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory response measured by IL-6/IL-10</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma concentration of asymmetric dimethyl arginine (ADMA</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Severe Sepsis</condition>
  <condition>Microcirculation</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dopamine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dobutamine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>enoximone</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nitroglycerine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>noradrenaline</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18 years or older

          -  admission to the intensive care unit with severe sepsis, defined in according with a
             modification of the American College of Chest Physician/SCCM guidelines criteria

          -  intention to provide full intensive care treatment for at least 72 hours and

          -  written informed consent to be obtained from patient or next of kin.

        Exclusion Criteria:

          -  haematologic malignancy

          -  metastatic malignancy

          -  AIDS with CD4 &lt; 50 cells/mm3

          -  liver cirrhosis Child Pugh B &amp; C

          -  pregnancy

          -  post resuscitation with GCS &lt; 8 of 15 and treatment with induced hypothermia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rutger v Raalte, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Onze Lieve Vrouwe Gasthuis, intensive care unit</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rutger v Raalte, MD</last_name>
    <phone>0031205993007</phone>
    <email>R.vanRaalte@olvg.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Peter vd Voort, MD</last_name>
    <phone>0031205993007</phone>
    <email>P.H.J.vanderVoort@olvg.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Onze Lieve Vrouwe Gasthuis, intensive care</name>
      <address>
        <city>Amsterdam</city>
        <zip>1090 HM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rutger v Raalte, MD</last_name>
      <phone>0031205993007</phone>
      <email>R.vanRaalte@olvg.nl</email>
    </contact>
    <investigator>
      <last_name>Rutger v Raalte, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2007</study_first_submitted>
  <study_first_submitted_qc>June 6, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2007</study_first_posted>
  <last_update_submitted>January 17, 2008</last_update_submitted>
  <last_update_submitted_qc>January 17, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 22, 2008</last_update_posted>
  <responsible_party>
    <name_title>R. van Raalte</name_title>
    <organization>Onze Lieve Vrouwe gasthuis</organization>
  </responsible_party>
  <keyword>sepsis</keyword>
  <keyword>severe sepsis</keyword>
  <keyword>microcirculation</keyword>
  <keyword>Orthogonal polarisation spectral</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dopamine</mesh_term>
    <mesh_term>Dobutamine</mesh_term>
    <mesh_term>Enoximone</mesh_term>
    <mesh_term>Norepinephrine</mesh_term>
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

